Susan Jones

Susan Jones

Chief Tech/Sci/R&D Officer at
ImmuRx, Inc.
66 year
Health Technology
Consumer Services
Commercial Services

Profile

Susan Dana Jones is the founder of Serenex, Inc., Waratah Pharmaceuticals, Inc. Dr. Jones is currently Director at Gene Solutions LLC, Vice President-Research & Development at ImmuRx, Inc., and Chief Technology Officer at Tourmaline Sub, Inc. Formerly, Dr. Jones was Senior Vice President-Product Development at Harpoon Therapeutics, Inc. from 2017 to 2022 and Chief Technology Officer at Tourmaline Bio, Inc. from 2023 to 2025.
Dr. Jones completed undergraduate studies at Harvard University and earned a doctorate from The University of California, San Francisco.

Susan Jones active positions

CompaniesPositionStart
Chief Tech/Sci/R&D Officer -
Director/Board Member -
Chief Tech/Sci/R&D Officer 2022-05-31

Former positions of Susan Jones

CompaniesPositionEnd
HARPOON THERAPEUTICS, INC. Corporate Officer/Principal 2022-04-30
Founder -
Founder -
See the detail of Susan Jones's experience

Training of Susan Jones

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

14

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!